Clearstead Trust’s CONMED CNMD Stock Holding History

Clearstead Trust’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16	Closed	-$753	–	1115
2025 Q3	$753	Hold	16	–	–	﹤0.01%	1295
2025 Q2	$834	Buy	+16	New	+$878	﹤0.01%	1217

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Clearstead Trust's CNMD Position: Q4 2025 in Review

Clearstead Trust sold out of CONMED (CNMD) in Q4 2025, closing a stake of 16 shares — an estimated $753 sold.

Clearstead Trust first reported a position in CNMD in Q2 2025 and held it in 2 quarters. The position peaked at $834 in Q2 2025. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

Clearstead Trust reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 16 CONMED shares in Q4 2025, an estimated $753.
Clearstead Trust first reported a position in CONMED in Q2 2025 and held it in 2 quarters.
Clearstead Trust's CONMED position peaked at $834 in Q2 2025.
265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.